Skip to main content

AACE 2024 Annual Meeting Main banner

Tweets by AACE 2024 Annual Meeting

Diabetes

Newest Incretin Options for Diabetes and Obesity

Saturday, May 11, 2024

2:30 PM – 3:30 PM CDT

Location: Celestin F-H, Level 3

CE: 1

CME/CE/MOC Credit

On-Demand Available For This Session

Learning Objectives:

safety and efficacy of dual and triple agonists as compared to GLP1RA
Safety and efficacy of new oral incretin-based therpaies
Benefits of incretin-based therapies beyond glucose lowering effects

Speaker(s)

Neda Rasouli, MD (she/her/hers)

University of Colorado
Denver, Colorado, United States

Slides

Moderator(s)

Archana Sadhu, MD, FACE

Director, System Diabetes Program and Director, Transplant Endocrinology
Houston Methodist
Houston, Texas, United States